Literature DB >> 7507754

Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease.

A G Tomasselli1, J L Sarcich, L J Barrett, I M Reardon, W J Howe, D B Evans, S K Sharma, R L Heinrikson.   

Abstract

A study has been made of the susceptibility of recombinant constructs of reverse transcriptase (RT) and ribonuclease H (RNase H) from human immunodeficiency virus type 1 (HIV-1) to digestion by the HIV-1 protease. At neutral pH, the protease attacks a single peptide bond, Phe440-Tyr441, in one of the protomers of the folded, active RT/RNase H (p66/p66) homodimer to give a stable, active heterodimer (p66/p51) that is resistant to further hydrolysis (Chattopadhyay, D., et al., 1992, J. Biol. Chem. 267, 14227-14232). The COOH-terminal p15 fragment released in the process, however, is rapidly degraded by the protease by cleavage at Tyr483-Leu484 and Tyr532-Leu533. In marked contrast to this p15 segment, both p66/p51 and a folded RNase H construct are stable to breakdown by the protease at neutral pH. It is only at pH values around 4 that these latter proteins appear to unfold and, under these conditions, the heterodimer undergoes extensive proteolysis. RNase H is also hydrolyzed at low pH, but cleavage takes place primarily at Gly436-Ala437 and at Phe440-Tyr441, and only much more slowly at residues 483, 494, and 532. This observation can be reconciled by inspection of crystallographic models of RNase H, which show that residues 483, 494, and 532 are relatively inaccessible in comparison to Gly436 and Phe440. Our results fit a model in which the p66/p66 homodimer exists in a conformation that mirrors that of the heterodimer, but with a p15 segment on one of the protomers that is structurally disordered to the extent that all of its potential HIV protease cleavage sites are accessible for hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7507754      PMCID: PMC2142316          DOI: 10.1002/pro.5560021216

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  32 in total

1.  Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases.

Authors:  L H Phylip; A D Richards; J Kay; J Kovalinka; P Strop; I Blaha; J Velek; V Kostka; A J Ritchie; A V Broadhurst
Journal:  Biochem Biophys Res Commun       Date:  1990-08-31       Impact factor: 3.575

2.  Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites.

Authors:  J T Griffiths; L H Phylip; J Konvalinka; P Strop; A Gustchina; A Wlodawer; R J Davenport; R Briggs; B M Dunn; J Kay
Journal:  Biochemistry       Date:  1992-06-09       Impact factor: 3.162

Review 3.  Proteolytic processing of polyproteins in the replication of RNA viruses.

Authors:  C U Hellen; H G Kräusslich; E Wimmer
Journal:  Biochemistry       Date:  1989-12-26       Impact factor: 3.162

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection.

Authors:  Y Rivière; V Blank; P Kourilsky; A Israël
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

6.  Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins.

Authors:  J Tözsér; I Bláha; T D Copeland; E M Wondrak; S Oroszlan
Journal:  FEBS Lett       Date:  1991-04-09       Impact factor: 4.124

7.  Three-dimensional structure of ribonuclease H from E. coli.

Authors:  K Katayanagi; M Miyagawa; M Matsushima; M Ishikawa; S Kanaya; M Ikehara; T Matsuzaki; K Morikawa
Journal:  Nature       Date:  1990-09-20       Impact factor: 49.962

8.  A recombinant ribonuclease H domain of HIV-1 reverse transcriptase that is enzymatically active.

Authors:  D B Evans; K Brawn; M R Deibel; W G Tarpley; S K Sharma
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

9.  Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.

Authors:  A G Tomasselli; M K Olsen; J O Hui; D J Staples; T K Sawyer; R L Heinrikson; C S Tomich
Journal:  Biochemistry       Date:  1990-01-09       Impact factor: 3.162

10.  Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.

Authors:  A G Tomasselli; J O Hui; T K Sawyer; D J Staples; C Bannow; I M Reardon; W J Howe; D L DeCamp; C S Craik; R L Heinrikson
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.486

View more
  17 in total

Review 1.  HIV-1 Reverse Transcriptase: A Metamorphic Protein with Three Stable States.

Authors:  Robert E London
Journal:  Structure       Date:  2019-01-10       Impact factor: 5.006

2.  Structural integrity of the ribonuclease H domain in HIV-1 reverse transcriptase.

Authors:  Ryan L Slack; Justin Spiriti; Jinwoo Ahn; Michael A Parniak; Daniel M Zuckerman; Rieko Ishima
Journal:  Proteins       Date:  2015-07-01

3.  NMR structure of the HIV-1 reverse transcriptase thumb subdomain.

Authors:  Naima G Sharaf; Andrew E Brereton; In-Ja L Byeon; P Andrew Karplus; Angela M Gronenborn
Journal:  J Biomol NMR       Date:  2016-11-17       Impact factor: 2.835

4.  Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.

Authors:  Michael E Abram; Michael A Parniak
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Ordered processing of the human immunodeficiency virus type 1 GagPol precursor is influenced by the context of the embedded viral protease.

Authors:  Steven C Pettit; Jose C Clemente; Jennifer A Jeung; Ben M Dunn; Andrew H Kaplan
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  The p66 immature precursor of HIV-1 reverse transcriptase.

Authors:  Naima G Sharaf; Eric Poliner; Ryan L Slack; Martin T Christen; In-Ja L Byeon; Michael A Parniak; Angela M Gronenborn; Rieko Ishima
Journal:  Proteins       Date:  2014-05-12

7.  Identification of structural mechanisms of HIV-1 protease specificity using computational peptide docking: implications for drug resistance.

Authors:  Sidhartha Chaudhury; Jeffrey J Gray
Journal:  Structure       Date:  2009-12-09       Impact factor: 5.006

8.  The mutation T477A in HIV-1 reverse transcriptase (RT) restores normal proteolytic processing of RT in virus with Gag-Pol mutated in the p51-RNH cleavage site.

Authors:  Michael E Abram; Stefan G Sarafianos; Michael A Parniak
Journal:  Retrovirology       Date:  2010-02-01       Impact factor: 4.602

9.  Unfolding the HIV-1 reverse transcriptase RNase H domain--how to lose a molecular tug-of-war.

Authors:  Xunhai Zheng; Lars C Pedersen; Scott A Gabel; Geoffrey A Mueller; Eugene F DeRose; Robert E London
Journal:  Nucleic Acids Res       Date:  2016-01-14       Impact factor: 16.971

10.  Mutations in the thumb allow human immunodeficiency virus type 1 reverse transcriptase to be cleaved by protease in virions.

Authors:  Linda L Dunn; Mary Jane McWilliams; Kalyan Das; Eddy Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.